Palumbo Wealth Management’s Assembly Biosciences ASMB Stock Holding History

Palumbo Wealth Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$545K	Sell	19,643 -17,662	-47%	-$504K	0.13%	116
2025 Q4	$1.27M	Buy	37,305 +2,507	+7%	+$80.7K	0.31%	61
2025 Q3	$891K	Buy	34,798 +16,131	+86%	+$354K	0.28%	65
2025 Q2	$338K	Buy	18,667 +681	+4%	+$8.98K	0.1%	133
2025 Q1	$172K	Buy	17,986 +6,559	+57%	+$85.8K	0.06%	171
2024 Q4	$180K	Buy	+11,427	New	+$184K	0.07%	156
2024 Q1	–	Sell	-840	Closed	-$8.26K	–	141
2023 Q4	$8.26K	Buy	+840	New	+$7.99K	﹤0.01%	123

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parkman Healthcare Partners Stamford, Connecticut $965M AUM 79.46% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return